300110 華仁藥業
按盤價 
3.290 +0.550 (+20.073%)
3.290 +0.550 (+20.073%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.349 | -43.289 | -68.512 | 7.199 | 7.375 |
| 總資產報酬率 ROA (%) | 1.047 | -15.102 | -31.848 | 3.642 | 3.346 |
| 投入資產回報率 ROIC (%) | 1.308 | -18.134 | -35.844 | 4.026 | 3.818 | 邊際利潤分析 |
| 銷售毛利率 (%) | 32.626 | 37.045 | 35.202 | 42.723 | 43.272 |
| 營業利潤率 (%) | 6.569 | -34.484 | -99.987 | 13.809 | 12.256 |
| 息稅前利潤/營業總收入 (%) | 9.619 | -31.529 | -96.138 | 17.959 | 16.754 |
| 淨利潤/營業總收入 (%) | 5.026 | -34.764 | -100.715 | 11.821 | 11.195 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 112.316 | -25.492 | -6.118 | 100.402 | 108.010 |
| 價值變動淨收益/利潤總額(%) | 0.969 | -1.049 | 0.086 | 0.366 | -0.673 |
| 營業外收支淨額/利潤總額(%) | -2.067 | 0.707 | 0.204 | 1.983 | 3.579 | 償債能力分析 |
| 流動比率 (X) | 0.801 | 0.674 | 0.766 | 1.841 | 1.345 |
| 速動比率 (X) | 0.624 | 0.510 | 0.560 | 1.620 | 1.214 |
| 資產負債率 (%) | 65.832 | 66.356 | 59.922 | 46.455 | 49.645 |
| 帶息債務/全部投入資本 (%) | 58.732 | 58.734 | 54.556 | 41.400 | 41.876 |
| 股東權益/帶息債務 (%) | 66.554 | 66.438 | 80.605 | 139.113 | 129.542 |
| 股東權益/負債合計 (%) | 47.866 | 46.732 | 63.324 | 112.266 | 98.742 |
| 利息保障倍數 (X) | 3.022 | -9.850 | -23.717 | 4.639 | 4.144 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 139.836 | 137.650 | 157.117 | 142.065 | 160.014 |
| 存貨周轉天數 (天) | 106.306 | 121.111 | 134.024 | 115.520 | 106.255 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 21/09/2026 16:09 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
